• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural basis of activity against aztreonam and extended spectrum cephalosporins for two carbapenem-hydrolyzing class D β-lactamases from Acinetobacter baumannii.鲍曼不动杆菌中两种碳青霉烯水解D类β-内酰胺酶对氨曲南和超广谱头孢菌素活性的结构基础
Biochemistry. 2015 Mar 17;54(10):1976-87. doi: 10.1021/bi501547k. Epub 2015 Mar 2.
2
Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.类 D 碳青霉烯酶 OXA-23 和 OXA-146 的结构:对碳青霉烯类、头孢菌素类和氨曲南的作用机制基础。
Antimicrob Agents Chemother. 2013 Oct;57(10):4848-55. doi: 10.1128/AAC.00762-13. Epub 2013 Jul 22.
3
Expanded Substrate Activity of OXA-24/40 in Carbapenem-Resistant Acinetobacter baumannii Involves Enhanced Binding Loop Flexibility.OXA-24/40在耐碳青霉烯鲍曼不动杆菌中的底物活性扩展涉及结合环灵活性增强。
Biochemistry. 2016 Nov 29;55(47):6535-6544. doi: 10.1021/acs.biochem.6b00806. Epub 2016 Nov 11.
4
Multiple substitutions lead to increased loop flexibility and expanded specificity in carbapenemase OXA-239.多种取代导致碳青霉烯酶 OXA-239 的环灵活性增加和特异性扩大。
Biochem J. 2018 Jan 11;475(1):273-288. doi: 10.1042/BCJ20170702.
5
Importance of the β5-β6 Loop for the Structure, Catalytic Efficiency, and Stability of Carbapenem-Hydrolyzing Class D β-Lactamase Subfamily OXA-143.β5-β6 环对于结构、催化效率和稳定性的重要性碳青霉烯水解酶 D 类β-内酰胺酶亚家族 OXA-143。
Biochemistry. 2019 Aug 27;58(34):3604-3616. doi: 10.1021/acs.biochem.9b00365. Epub 2019 Aug 15.
6
Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii.ADC-68的结构,一种从鲍曼不动杆菌中分离出的新型碳青霉烯水解C类超广谱β-内酰胺酶。
Acta Crystallogr D Biol Crystallogr. 2014 Nov;70(Pt 11):2924-36. doi: 10.1107/S1399004714019543. Epub 2014 Oct 23.
7
Hydrolytic mechanism of OXA-58 enzyme, a carbapenem-hydrolyzing class D β-lactamase from Acinetobacter baumannii.鲍曼不动杆菌碳青霉烯酶 OXA-58 的水解机制。
J Biol Chem. 2011 Oct 28;286(43):37292-303. doi: 10.1074/jbc.M111.280115. Epub 2011 Aug 31.
8
Clinical Variants of the Native Class D β-Lactamase of Acinetobacter baumannii Pose an Emerging Threat through Increased Hydrolytic Activity against Carbapenems.鲍曼不动杆菌天然D类β-内酰胺酶的临床变体通过增强对碳青霉烯类的水解活性构成新出现的威胁。
Antimicrob Agents Chemother. 2016 Sep 23;60(10):6155-64. doi: 10.1128/AAC.01277-16. Print 2016 Oct.
9
Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D β-Lactamases.D类β-内酰胺酶OXA-51家族中碳青霉烯酶活性增强的结构基础。
ACS Chem Biol. 2015 Aug 21;10(8):1791-6. doi: 10.1021/acschembio.5b00090. Epub 2015 Jun 12.
10
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens.两种密切相关的D类β-内酰胺酶不同底物谱的结构基础及其卤素抑制作用
Biochemistry. 2015 Jun 2;54(21):3370-80. doi: 10.1021/acs.biochem.5b00298. Epub 2015 May 14.

引用本文的文献

1
Diversity in the Common Fold: Structural Insights into Class D β-Lactamases from Gram-Negative Pathogens.常见结构中的多样性:革兰氏阴性病原体D类β-内酰胺酶的结构洞察
Pathogens. 2025 Aug 1;14(8):761. doi: 10.3390/pathogens14080761.
2
Structural comparison of substrate-binding pockets of serine β-lactamases in classes A, C, and D.A、C和D类丝氨酸β-内酰胺酶底物结合口袋的结构比较
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2435365. doi: 10.1080/14756366.2024.2435365. Epub 2024 Dec 23.
3
Simultaneous enhancement of multiple functional properties using evolution-informed protein design.利用进化启发的蛋白质设计同时增强多种功能特性。
Nat Commun. 2024 Jun 20;15(1):5141. doi: 10.1038/s41467-024-49119-x.
4
Structural and Dynamic Features of Acinetobacter baumannii OXA-66 β-Lactamase Explain Its Stability and Evolution of Novel Variants.鲍曼不动杆菌 OXA-66β-内酰胺酶的结构和动态特征解释了其稳定性和新型变异体的进化。
J Mol Biol. 2024 Jun 15;436(12):168603. doi: 10.1016/j.jmb.2024.168603. Epub 2024 May 8.
5
The Dynamics of OXA-23 β-Lactamase from .OXA-23 β-内酰胺酶的动力学研究。
Int J Mol Sci. 2023 Dec 15;24(24):17527. doi: 10.3390/ijms242417527.
6
Simultaneous enhancement of multiple functional properties using evolution-informed protein design.利用进化信息蛋白质设计同时增强多种功能特性
bioRxiv. 2023 May 9:2023.05.09.539914. doi: 10.1101/2023.05.09.539914.
7
Sulfonamidoboronic Acids as "Cross-Class" Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in .磺酰胺硼酸作为广谱C类头孢菌素酶ADC - 33和D类碳青霉烯酶OXA - 24/40的“跨类”抑制剂:对抗耐药性的策略性化合物设计
Antibiotics (Basel). 2023 Mar 24;12(4):644. doi: 10.3390/antibiotics12040644.
8
Two non-active site residues W165 and L166 prominently influence the beta-lactam hydrolytic ability of OXA-23 beta-lactamase.两个非活性位点残基 W165 和 L166 显著影响 OXA-23 β-内酰胺酶的β-内酰胺水解能力。
J Antibiot (Tokyo). 2023 Aug;76(8):489-498. doi: 10.1038/s41429-023-00624-z. Epub 2023 Apr 24.
9
Resistance to aztreonam-avibactam due to CTX-M-15 in the presence of penicillin-binding protein 3 with extra amino acids in .在存在带有额外氨基酸的青霉素结合蛋白3的情况下,因CTX-M-15导致对氨曲南-阿维巴坦耐药。
Front Microbiol. 2022 Nov 4;13:1047109. doi: 10.3389/fmicb.2022.1047109. eCollection 2022.
10
β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates.β-内酰胺抗生素的作用靶点与耐药机制:从共价抑制剂到底物
RSC Med Chem. 2021 Aug 4;12(10):1623-1639. doi: 10.1039/d1md00200g. eCollection 2021 Oct 20.

本文引用的文献

1
β-Lactam Antibiotics Renaissance.β-内酰胺类抗生素的复兴。
Antibiotics (Basel). 2014 May 9;3(2):193-215. doi: 10.3390/antibiotics3020193.
2
A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing Acinetobacter pittii sequence type 119 in Australia.澳大利亚一例产IMP-4、OXA-421、OXA-96和CARB-2的皮特不动杆菌序列型119病例。
J Clin Microbiol. 2015 Feb;53(2):727-30. doi: 10.1128/JCM.02726-14. Epub 2014 Nov 26.
3
OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain.OXA-207,一种来自西班牙皮氏不动杆菌的新型OXA-24变体,对碳青霉烯类药物的催化效率降低。
Antimicrob Agents Chemother. 2014 Aug;58(8):4944-8. doi: 10.1128/AAC.02633-13. Epub 2014 Jun 2.
4
Crystal structure of carbapenemase OXA-58 from Acinetobacter baumannii.鲍曼不动杆菌碳青霉烯酶OXA-58的晶体结构
Antimicrob Agents Chemother. 2014;58(4):2135-43. doi: 10.1128/AAC.01983-13. Epub 2014 Jan 27.
5
Structural origins of oxacillinase specificity in class D β-lactamases.D 类β-内酰胺酶中环丙沙星酶特异性的结构起源。
Antimicrob Agents Chemother. 2014;58(1):333-41. doi: 10.1128/AAC.01483-13. Epub 2013 Oct 28.
6
Structural basis for carbapenemase activity of the OXA-23 β-lactamase from Acinetobacter baumannii.鲍曼不动杆菌OXA-23β-内酰胺酶碳青霉烯酶活性的结构基础。
Chem Biol. 2013 Sep 19;20(9):1107-15. doi: 10.1016/j.chembiol.2013.07.015. Epub 2013 Sep 5.
7
Class D β-lactamases: a reappraisal after five decades.D 类 β-内酰胺酶:五十年后的再评价。
Acc Chem Res. 2013 Nov 19;46(11):2407-15. doi: 10.1021/ar300327a. Epub 2013 Jul 31.
8
Structures of the class D Carbapenemases OXA-23 and OXA-146: mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam.类 D 碳青霉烯酶 OXA-23 和 OXA-146 的结构:对碳青霉烯类、头孢菌素类和氨曲南的作用机制基础。
Antimicrob Agents Chemother. 2013 Oct;57(10):4848-55. doi: 10.1128/AAC.00762-13. Epub 2013 Jul 22.
9
Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters.BAL30072 单独或联合β-内酰胺酶抑制剂或美罗培南对碳青霉烯类耐药肠杆菌科和非发酵菌的活性。
J Antimicrob Chemother. 2013 Jul;68(7):1601-8. doi: 10.1093/jac/dkt050. Epub 2013 Feb 28.
10
Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.头孢他啶-阿维巴坦:一种新型头孢菌素/β-内酰胺酶抑制剂复方制剂。
Drugs. 2013 Feb;73(2):159-77. doi: 10.1007/s40265-013-0013-7.

鲍曼不动杆菌中两种碳青霉烯水解D类β-内酰胺酶对氨曲南和超广谱头孢菌素活性的结构基础

Structural basis of activity against aztreonam and extended spectrum cephalosporins for two carbapenem-hydrolyzing class D β-lactamases from Acinetobacter baumannii.

作者信息

Mitchell Joshua M, Clasman Jozlyn R, June Cynthia M, Kaitany Kip-Chumba J, LaFleur James R, Taracila Magdalena A, Klinger Neil V, Bonomo Robert A, Wymore Troy, Szarecka Agnieszka, Powers Rachel A, Leonard David A

机构信息

∥Departments of Medicine, Pharmacology, Biochemistry, and Molecular Biology and Microbiology, Case Western Reserve University and Research Service, and Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.

⊥UT/ORNL Center for Molecular Biophysics, Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831, United States.

出版信息

Biochemistry. 2015 Mar 17;54(10):1976-87. doi: 10.1021/bi501547k. Epub 2015 Mar 2.

DOI:10.1021/bi501547k
PMID:25710192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4476283/
Abstract

The carbapenem-hydrolyzing class D β-lactamases OXA-23 and OXA-24/40 have emerged worldwide as causative agents for β-lactam antibiotic resistance in Acinetobacter species. Many variants of these enzymes have appeared clinically, including OXA-160 and OXA-225, which both contain a P → S substitution at homologous positions in the OXA-24/40 and OXA-23 backgrounds, respectively. We purified OXA-160 and OXA-225 and used steady-state kinetic analysis to compare the substrate profiles of these variants to their parental enzymes, OXA-24/40 and OXA-23. OXA-160 and OXA-225 possess greatly enhanced hydrolytic activities against aztreonam, ceftazidime, cefotaxime, and ceftriaxone when compared to OXA-24/40 and OXA-23. These enhanced activities are the result of much lower Km values, suggesting that the P → S substitution enhances the binding affinity of these drugs. We have determined the structures of the acylated forms of OXA-160 (with ceftazidime and aztreonam) and OXA-225 (ceftazidime). These structures show that the R1 oxyimino side-chain of these drugs occupies a space near the β5-β6 loop and the omega loop of the enzymes. The P → S substitution found in OXA-160 and OXA-225 results in a deviation of the β5-β6 loop, relieving the steric clash with the R1 side-chain carboxypropyl group of aztreonam and ceftazidime. These results reveal worrying trends in the enhancement of substrate spectrum of class D β-lactamases but may also provide a map for β-lactam improvement.

摘要

碳青霉烯水解D类β-内酰胺酶OXA-23和OXA-24/40已在全球范围内出现,成为不动杆菌属中β-内酰胺类抗生素耐药的病原体。这些酶的许多变体已在临床上出现,包括OXA-160和OXA-225,它们分别在OXA-24/40和OXA-23背景的同源位置含有P→S取代。我们纯化了OXA-160和OXA-225,并使用稳态动力学分析来比较这些变体与其亲本酶OXA-24/40和OXA-23的底物谱。与OXA-24/40和OXA-23相比,OXA-160和OXA-225对氨曲南、头孢他啶、头孢噻肟和头孢曲松具有大大增强的水解活性。这些增强的活性是由于Km值低得多的结果,表明P→S取代增强了这些药物的结合亲和力。我们已经确定了OXA-160(与头孢他啶和氨曲南)和OXA-225(头孢他啶)的酰化形式的结构。这些结构表明,这些药物的R1肟基侧链占据了酶β5-β6环和ω环附近的空间。在OXA-160和OXA-225中发现的P→S取代导致β5-β6环的偏差,缓解了与氨曲南和头孢他啶的R1侧链羧丙基的空间冲突[14,15]。这些结果揭示了D类β-内酰胺酶底物谱增强的令人担忧的趋势,但也可能为β-内酰胺的改进提供一个图谱。